CLINICAL_TRIALS ClinicalTrials.gov record update

Reversal of Moderate (With the Use of Neostigmine 60 mcg/kg) or Superficial (With the Use of Neostigmine 30 mcg/kg) Neuromuscular Blockade Induced by Cisatracurium. A Prospective, Randomized, Controlled and Doubled Blinded Clinical Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04920682
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:39.254699+00:00
Published At: 2022-05-19T00:00:00+00:00
Record Updated At: 2022-05-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neostigmine", "Neuromuscular Blocking Agents", "Muscle Weakness"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-05-19"
protocolSection.identificationModule.nctId: "NCT04920682"
protocolSection.identificationModule.officialTitle: "Reversal of Moderate (With the Use of Neostigmine 60 mcg/kg) or Superficial (With the Use of Neostigmine 30 mcg/kg) Neuromuscular Blockade Induced by Cisatracurium. A Prospective, Randomized, Controlled and Doubled Blinded Clinical Trial"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.